{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:18:23Z","timestamp":1790338703382,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1465-9921-11-90","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T02:16:33Z","timestamp":1279592193000},"source":"Crossref","is-referenced-by-count":78,"title":["Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis"],"prefix":"10.1186","volume":"11","author":[{"given":"Avraham","family":"Beigelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra L","family":"Mikols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P","family":"Gunsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn L","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L","family":"Brody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,30]]},"reference":[{"issue":"6","key":"933_CR1_933","first-page":"543","volume":"140","author":"WP Glezen","year":"1986","unstructured":"Glezen WP, Taber LH, Frank AL, Kasel JA: Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986,140(6):543\u2013546.","journal-title":"Am J Dis Child"},{"issue":"6","key":"933_CR2_933","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1067\/mpd.2000.110531","volume":"137","author":"TG Boyce","year":"2000","unstructured":"Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR: Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr 2000,137(6):865\u2013870.","journal-title":"J Pediatr"},{"issue":"15","key":"933_CR3_933","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/jama.282.15.1440","volume":"282","author":"DK Shay","year":"1999","unstructured":"Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ: Bronchiolitis-associated hospitalizations among US children, 1980\u20131996. JAMA 1999,282(15):1440\u20131446.","journal-title":"JAMA"},{"issue":"7","key":"933_CR4_933","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/00006454-200207000-00005","volume":"21","author":"S Leader","year":"2002","unstructured":"Leader S, Kohlhase K: Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatr Infect Dis J 2002,21(7):629\u2013632.","journal-title":"Pediatr Infect Dis J"},{"issue":"3 Pt 2","key":"933_CR5_933","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1164\/ajrccm.163.supplement_1.2011109","volume":"163","author":"N Sigurs","year":"2001","unstructured":"Sigurs N: Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link. Am J Respir Crit Care Med 2001,163(3 Pt 2):S2\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"933_CR6_933","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1164\/ajrccm.161.5.9906076","volume":"161","author":"N Sigurs","year":"2000","unstructured":"Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B: Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000,161(5):1501\u20131507.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"933_CR7_933","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1164\/rccm.200406-730OC","volume":"171","author":"N Sigurs","year":"2005","unstructured":"Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, Kjellman B: Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005,171(2):137\u2013141.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"933_CR8_933","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jaci.2008.07.010","volume":"122","author":"M Castro","year":"2008","unstructured":"Castro M, Schweiger T, Yin-Declue H, Ramkumar TP, Christie C, Zheng J, Cohen R, Schechtman KB, Strunk R, Bacharier LB: Cytokine response after severe respiratory syncytial virus bronchiolitis in early life. J Allergy Clin Immunol 2008,122(4):726\u2013733.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"933_CR9_933","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jaci.2009.02.021","volume":"123","author":"KN Carroll","year":"2009","unstructured":"Carroll KN, Wu P, Gebretsadik T, Griffin MR, Dupont WD, Mitchel EF, Hartert TV: The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. J Allergy Clin Immunol 2009,123(5):1055\u20131061.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"933_CR10_933","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.283.4.499","volume":"283","author":"WP Glezen","year":"2000","unstructured":"Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB: Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000,283(4):499\u2013505.","journal-title":"JAMA"},{"key":"933_CR11_933","doi-asserted-by":"crossref","unstructured":"Diagnosis and management of bronchiolitis Pediatrics 2006,118(4):1774\u20131793.","DOI":"10.1542\/peds.2006-2223"},{"issue":"3","key":"933_CR12_933","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.prrv.2005.06.005","volume":"6","author":"M Shinkai","year":"2005","unstructured":"Shinkai M, Rubin BK: Macrolides and airway inflammation in children. Paediatr Respir Rev 2005,6(3):227\u2013235.","journal-title":"Paediatr Respir Rev"},{"issue":"10","key":"933_CR13_933","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1136\/thx.52.10.915","volume":"52","author":"H Koyama","year":"1997","unstructured":"Koyama H, Geddes DM: Erythromycin and diffuse panbronchiolitis. Thorax 1997,52(10):915\u2013918.","journal-title":"Thorax"},{"issue":"9338","key":"933_CR14_933","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S0140-6736(02)11081-6","volume":"360","author":"A Equi","year":"2002","unstructured":"Equi A, Balfour-Lynn IM, Bush A, Rosenthal M: Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet 2002,360(9338):978\u2013984.","journal-title":"Lancet"},{"issue":"3","key":"933_CR15_933","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1378\/chest.99.3.670","volume":"99","author":"H Miyatake","year":"1991","unstructured":"Miyatake H, Taki F, Taniguchi H, Suzuki R, Takagi K, Satake T: Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 1991,99(3):670\u2013673.","journal-title":"Chest"},{"issue":"2","key":"933_CR16_933","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1378\/chest.106.2.458","volume":"106","author":"T Shimizu","year":"1994","unstructured":"Shimizu T, Kato M, Mochizuki H, Tokuyama K, Morikawa A, Kuroume T: Roxithromycin reduces the degree of bronchial hyperresponsiveness in children with asthma. Chest 1994,106(2):458\u2013461.","journal-title":"Chest"},{"issue":"3","key":"933_CR17_933","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3109\/02770909509089507","volume":"32","author":"H Kamoi","year":"1995","unstructured":"Kamoi H, Kurihara N, Fujiwara H, Hirata K, Takeda T: The macrolide antibacterial roxithromycin reduces bronchial hyperresponsiveness and superoxide anion production by polymorphonuclear leukocytes in patients with asthma. J Asthma 1995,32(3):191\u2013197.","journal-title":"J Asthma"},{"issue":"3","key":"933_CR18_933","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/02770909709068191","volume":"34","author":"T Shimizu","year":"1997","unstructured":"Shimizu T, Kato M, Mochizuki H, Takei K, Maeda S, Tokuyama K, Morikawa A: Roxithromycin attenuates acid-induced cough and water-induced bronchoconstriction in children with asthma. J Asthma 1997,34(3):211\u2013217.","journal-title":"J Asthma"},{"issue":"6","key":"933_CR19_933","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S1081-1206(10)62409-X","volume":"84","author":"H Amayasu","year":"2000","unstructured":"Amayasu H, Yoshida S, Ebana S, Yamamoto Y, Nishikawa T, Shoji T, Nakagawa H, Hasegawa H, Nakabayashi M, Ishizaki Y: Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann Allergy Asthma Immunol 2000,84(6):594\u2013598.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"933_CR20_933","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1164\/ajrccm.164.4.2011040","volume":"164","author":"PN Black","year":"2001","unstructured":"Black PN, Blasi F, Jenkins CR, Scicchitano R, Mills GD, Rubinfeld AR, Ruffin RE, Mullins PR, Dangain J, Cooper BC, David DB, Allegra L: Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 2001,164(4):536\u2013541.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"933_CR21_933","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1081\/JAS-120002199","volume":"39","author":"A Ekici","year":"2002","unstructured":"Ekici A, Ekici M, Erdemoglu AK: Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma. J Asthma 2002,39(2):181\u2013185.","journal-title":"J Asthma"},{"issue":"6","key":"933_CR22_933","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1378\/chest.121.6.1782","volume":"121","author":"M Kraft","year":"2002","unstructured":"Kraft M, Cassell GH, Pak J, Martin RJ: Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 2002,121(6):1782\u20131788.","journal-title":"Chest"},{"issue":"5","key":"933_CR23_933","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1183\/09031936.04.00118404","volume":"23","author":"E Kostadima","year":"2004","unstructured":"Kostadima E, Tsiodras S, Alexopoulos EI, Kaditis AG, Mavrou I, Georgatou N, Papamichalopoulos A: Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma. Eur Respir J 2004,23(5):714\u2013717.","journal-title":"Eur Respir J"},{"issue":"15","key":"933_CR24_933","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa044080","volume":"354","author":"SL Johnston","year":"2006","unstructured":"Johnston SL, Blasi F, Black PN, Martin RJ, Farrell DJ, Nieman RB: The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 2006,354(15):1589\u20131600.","journal-title":"N Engl J Med"},{"issue":"2","key":"933_CR25_933","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2500\/aap.2007.28.2958","volume":"28","author":"GL Piacentini","year":"2007","unstructured":"Piacentini GL, Peroni DG, Bodini A, Pigozzi R, Costella S, Loiacono A, Boner AL: Azithromycin reduces bronchial hyperresponsiveness and neutrophilic airway inflammation in asthmatic children: a preliminary report. Allergy Asthma Proc 2007,28(2):194\u2013198.","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"933_CR26_933","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/ppul.20748","volume":"43","author":"MC Kneyber","year":"2008","unstructured":"Kneyber MC, van Woensel JB, Uijtendaal E, Uiterwaal CS, Kimpen JL: Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: a randomized equivalence trial. Pediatr Pulmonol 2008,43(2):142\u2013149.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"933_CR27_933","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1183\/09031936.00029206","volume":"29","author":"F Tahan","year":"2007","unstructured":"Tahan F, Ozcan A, Koc N: Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial. Eur Respir J 2007,29(1):91\u201397.","journal-title":"Eur Respir J"},{"issue":"6","key":"933_CR28_933","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nm1770","volume":"14","author":"EY Kim","year":"2008","unstructured":"Kim EY, Battaile JT, Patel AC, You Y, Agapov E, Grayson MH, Benoit LA, Byers DE, Alevy Y, Tucker J, Swanson S, Tidwell R, Tyner JW, Morton JD, Castro M, Polineni D, Patterson GA, Schwendener RA, Allard JD, Peltz G, Holtzman MJ: Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med 2008,14(6):633\u2013640.","journal-title":"Nat Med"},{"issue":"2","key":"933_CR29_933","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1172\/JCI0214345","volume":"110","author":"MJ Walter","year":"2002","unstructured":"Walter MJ, Morton JD, Kajiwara N, Agapov E, Holtzman MJ: Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J Clin Invest 2002,110(2):165\u2013175.","journal-title":"J Clin Invest"},{"issue":"2","key":"933_CR30_933","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1378\/chest.08-3056","volume":"136","author":"A Beigelman","year":"2009","unstructured":"Beigelman A, Gunsten S, Mikols CL, Vidavsky I, Cannon CL, Brody SL, Walter MJ: Azithromycin Attenuates Airway Inflammation in a Noninfectious Mouse Model of Allergic Asthma. Chest 2009,136(2):498\u2013506.","journal-title":"Chest"},{"issue":"4","key":"933_CR31_933","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1365-2567.2008.02923.x","volume":"126","author":"S Gunsten","year":"2009","unstructured":"Gunsten S, Mikols CL, Grayson MH, Schwendener RA, Agapov E, Tidwell RM, Cannon CL, Brody SL, Walter MJ: IL-12 p80-dependent macrophage recruitment primes the host for increased survival following a lethal respiratory viral infection. Immunology 2009,126(4):500\u2013513.","journal-title":"Immunology"},{"issue":"4","key":"933_CR32_933","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1164\/rccm.200512-1886OC","volume":"174","author":"CL Mikols","year":"2006","unstructured":"Mikols CL, Yan L, Norris JY, Russell TD, Khalifah AP, Hachem RR, Chakinala MM, Yusen RD, Castro M, Kuo E, Patterson GA, Mohanakumar T, Trulock EP, Walter MJ: IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction. Am J Respir Crit Care Med 2006,174(4):461\u2013470.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"933_CR33_933","doi-asserted-by":"publisher","first-page":"6866","DOI":"10.4049\/jimmunol.171.12.6866","volume":"171","author":"TD Russell","year":"2003","unstructured":"Russell TD, Yan Q, Fan G, Khalifah AP, Bishop DK, Brody SL, Walter MJ: IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta 1. J Immunol 2003,171(12):6866\u20136874.","journal-title":"J Immunol"},{"issue":"10","key":"933_CR34_933","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1128\/AAC.01011-06","volume":"51","author":"N Hoffmann","year":"2007","unstructured":"Hoffmann N, Lee B, Hentzer M, Rasmussen TB, Song Z, Johansen HK, Givskov M, Hoiby N: Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-\/-) mice. Antimicrob Agents Chemother 2007,51(10):3677\u20133687.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"933_CR35_933","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1128\/AAC.40.7.1617","volume":"40","author":"JE Conte Jr","year":"1996","unstructured":"Conte JE Jr, Golden J, Duncan S, McKenna E, Lin E, Zurlinden E: Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. Antimicrob Agents Chemother 1996,40(7):1617\u20131622.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"933_CR36_933","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1164\/rccm.200609-1292OC","volume":"176","author":"Z Bao","year":"2007","unstructured":"Bao Z, Lim S, Liao W, Lin Y, Thiemermann C, Leung BP, Wong WS: Glycogen synthase kinase-3beta inhibition attenuates asthma in mice. Am J Respir Crit Care Med 2007,176(5):431\u2013438.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"933_CR37_933","doi-asserted-by":"publisher","first-page":"7053","DOI":"10.4049\/jimmunol.172.11.7053","volume":"172","author":"W Duan","year":"2004","unstructured":"Duan W, Chan JH, Wong CH, Leung BP, Wong WS: Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J Immunol 2004,172(11):7053\u20137059.","journal-title":"J Immunol"},{"issue":"6","key":"933_CR38_933","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0002-9440(10)63057-X","volume":"159","author":"DC Look","year":"2001","unstructured":"Look DC, Walter MJ, Williamson MR, Pang L, You Y, Sreshta JN, Johnson JE, Zander DS, Brody SL: Effects of paramyxoviral infection on airway epithelial cell Foxj1 expression, ciliogenesis, and mucociliary function. Am J Pathol 2001,159(6):2055\u20132069.","journal-title":"Am J Pathol"},{"issue":"3 Pt 1","key":"933_CR39_933","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1164\/ajrccm.157.3.9703098","volume":"157","author":"K Sato","year":"1998","unstructured":"Sato K, Suga M, Akaike T, Fujii S, Muranaka H, Doi T, Maeda H, Ando M: Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice. Am J Respir Crit Care Med 1998,157(3 Pt 1):853\u2013857.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"933_CR40_933","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.antiviral.2009.05.003","volume":"83","author":"M Asada","year":"2009","unstructured":"Asada M, Yoshida M, Suzuki T, Hatachi Y, Sasaki T, Yasuda H, Nakayama K, Nishimura H, Nagatomi R, Kubo H, Yamaya M: Macrolide antibiotics inhibit respiratory syncytial virus infection in human airway epithelial cells. Antiviral Res 2009,83(2):191\u2013200.","journal-title":"Antiviral Res"},{"issue":"1-2","key":"933_CR41_933","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejphar.2006.03.074","volume":"539","author":"V Ivetic Tkalcevic","year":"2006","unstructured":"Ivetic Tkalcevic V, Bosnjak B, Hrvacic B, Bosnar M, Marjanovic N, Ferencic Z, Situm K, Culic O, Parnham MJ, Erakovic V: Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice. Eur J Pharmacol 2006,539(1\u20132):131\u2013138.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"933_CR42_933","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1378\/chest.07-3056","volume":"134","author":"M Leiva","year":"2008","unstructured":"Leiva M, Ruiz-Bravo A, Jimenez-Valera M: Effects of telithromycin in in vitro and in vivo models of lipopolysaccharide-induced airway inflammation. Chest 2008,134(1):20\u201329.","journal-title":"Chest"},{"issue":"12","key":"933_CR43_933","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1164\/rccm.200402-200OC","volume":"170","author":"WC Tsai","year":"2004","unstructured":"Tsai WC, Rodriguez ML, Young KS, Deng JC, Thannickal VJ, Tateda K, Hershenson MB, Standiford TJ: Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. Am J Respir Crit Care Med 2004,170(12):1331\u20131339.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"933_CR44_933","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1086\/425516","volume":"190","author":"JL Harcourt","year":"2004","unstructured":"Harcourt JL, Karron RA, Tripp RA: Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis. J Infect Dis 2004,190(11):1936\u20131940.","journal-title":"J Infect Dis"},{"key":"933_CR45_933","doi-asserted-by":"crossref","unstructured":"Zhang W, Choi Y, Haynes LM, Harcourt JL, Anderson LJ, Jones LP, Tripp RA: Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice. J Virol 84(2):1148\u20131157.","DOI":"10.1128\/JVI.01755-09"},{"issue":"3","key":"933_CR46_933","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1086\/600108","volume":"200","author":"LM Haynes","year":"2009","unstructured":"Haynes LM, Caidi H, Radu GU, Miao C, Harcourt JL, Tripp RA, Anderson LJ: Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB\/c mice. J Infect Dis 2009,200(3):439\u2013447.","journal-title":"J Infect Dis"},{"issue":"6","key":"933_CR47_933","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1128\/AAC.42.6.1499","volume":"42","author":"S Kawasaki","year":"1998","unstructured":"Kawasaki S, Takizawa H, Ohtoshi T, Takeuchi N, Kohyama T, Nakamura H, Kasama T, Kobayashi K, Nakahara K, Morita Y, Yamamoto K: Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro. Antimicrob Agents Chemother 1998,42(6):1499\u20131502.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6 Pt 2","key":"933_CR48_933","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1016\/S0091-6749(96)70068-4","volume":"98","author":"T Adachi","year":"1996","unstructured":"Adachi T, Motojima S, Hirata A, Fukuda T, Kihara N, Kosaku A, Ohtake H, Makino S: Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5. J Allergy Clin Immunol 1996,98(6 Pt 2):S207\u2013215.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"933_CR49_933","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-7961-2-4","volume":"2","author":"U Hatipoglu","year":"2004","unstructured":"Hatipoglu U, Rubinstein I: Low-dose, long-term macrolide therapy in asthma: An overview. Clin Mol Allergy 2004,2(1):4.","journal-title":"Clin Mol Allergy"},{"issue":"8","key":"933_CR50_933","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3201\/eid1508.081187","volume":"15","author":"SG Jenkins","year":"2009","unstructured":"Jenkins SG, Farrell DJ: Increase in pneumococcus macrolide resistance, United States. Emerg Infect Dis 2009,15(8):1260\u20131264.","journal-title":"Emerg Infect Dis"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-11-90","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T05:07:27Z","timestamp":1559279247000},"score":1,"resource":{"primary":{"URL":"http:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-11-90"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,30]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["933"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-11-90","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,30]]},"article-number":"90"}}